
Jonathan Fialkow
@jonfialkowmd
can't decide whether to promote anti-sugar, cardiac health or NY sports teams (Mets,Jets, Knicks and Isles)....so I'll do both! AND..I LOVE DOGS!
ID: 3436174469
23-08-2015 01:05:48
578 Tweet
251 Followers
1,1K Following

And if I can take a moment to emphatically thank YOU, Khurram Nasir 🙏🙏🙏 Had you and your team not have initiated the #MiamiHeartStudy, we'd have no sizable comparison dataset to gather metabolically healthy, matched controls.





I speak with Virta Health CEO Sami Inkinen about reversing Type 2 diabetes, the GLP-1 craze, and his entrepreneurial journey. x.com/i/broadcasts/1…


Wonderful job by Maura Falli highlighting multidisciplinary work done Baptist Health to care for our patients at #ACC24 Jonathan Fialkow


Great Bishop keynote lecture by Dr. #JerryBlackwell on the Future of Cardiology. So many key points on role of “middlemen” in payment, opaque prices, threats to professionalism. See on #ACCAnywhere if you missed it. American College of Cardiology ACC Advocacy MedAxiom


So proud of our APP, Wendy Cardenas for presenting her work on impact of PAP on cardiometabolic parameters #SLEEP2024 Cardiometabolic Center Alliance Jonathan Fialkow Baptist Health Tom C. Nguyen, MD Baptist Health Academics


Dr. Jonathan Fialkow, Deputy Director of Baptist Health Miami Cardiac & Vascular Institute, talks to Reuters Health discussing the latest evidence showing certain #weightloss drugs can reduce #heartdisease risk and treat other #health issues. Read the full story:



Lipoprotein(a) and Coronary Plaque in Asymptomatic Individuals: The Miami Heart Study at Baptist Health South Florida | Circulation: Cardiovascular Imaging ahajournals.org/doi/10.1161/CI… Reed Mszar Khurram Nasir Miguel Cainzos-Achirica



Heterogeneity exists in subclinical ath across LDL-C, CAC and estimated 🫀 risk levels. The value of CCTA in risk-stratifying asymptomatic 👫 could be explored further 🔗atherosclerosis-journal.com/article/S0021-… Khurram Nasir Reed Mszar Miguel Cainzos-Achirica Michael D. Shapiro Jonathan Fialkow Sadeer Al-Kindi, MD


💡Join our upcoming webinar hosted by Jonathan Fialkow with Dr. Mikhail Kosiborod (Mikhail Kosiborod) discussing the latest on SGLT2 inhibitors and GLP1 receptor agonists in managing heart and kidney health. Register now ➡️bapth.lt/HotM #MedEd #MedTwitter



Wonderful to see! Deep respect to Nathan Wong & Erin D. Michos, M.D. for their outstanding leadership and stewardship of AJPC these past years. Khurram Nasir is an incredible mind and will bring innovation and genuine passion for moving the field forward. Congratulations! ASPC